Exendin-(9-39) Effects on Glucose and Insulin in Children With Congenital Hyperinsulinism During Fasting and During a Meal and a Protein Challenge.
Darko StefanovskiMary E VajraveluStephanie GivlerDiva D De LeónPublished in: Diabetes care (2022)
These results support a therapeutic potential of exendin-(9-39) to prevent fasting and protein-induced hypoglycemia in children with HI.